// App-Quantinova.ai

OP0221 (2021) : TARGETED METABOLOMIC PROFILING AND PREDICTION OF CARDIOVASCULAR EVENTS: A PROSPECTIVE STUDY OF PATIENTS WITH PSORIATIC ARTHRITIS AND PSORIASIS

Researchers

Presenter

  • K. Colaco

Principal Investigators

  • K. A. Lee

  • S. Akhtari

  • P. Welsh

  • N. Sattar

  • I. Mcinnes

  • V. Chandran

  • P. Harvey

  • R. Cook

  • D. D. Gladman

  • V. Piguet

  • L. Eder

Medical Centers

  • Women’s College Hospital, Women’s College Research Institute, Toronto, Canada

  • University Health Network, Krembil Research Institute, Toronto, Canada

  • University of Toronto, Institute of Medical Science, Toronto, Canada

  • University of Waterloo, Statistics and Actuarial Science, Waterloo, Canada

  • Women's College Hospital, Cardiology, Toronto, Canada

  • Rambam Health Care Campus, Haifa, Israel

  • University of Glasgow, Institute of Cancer Sciences, Glasgow, United Kingdom

  • University of Glasgow, Institute of Infection Immunity and Inflammation, Glasgow, United Kingdom

  • University of Toronto, Faculty of Medicine, Toronto,Canada

  • Toronto Western Hospital, Centre for Prognosis in the Rheumatic Diseases, Toronto, Canada

Locations

  • Canada

  • Israel

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

  • Musculoskeletal

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

Disease

  • Transient Ischemic Attack

  • Congestive heart failure

  • Ischemic stroke

  • Myocardial infarction

  • Psoriatic arthritis

  • Inflammatory Arthritis

  • Psoriasis

  • Angina

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A